The incidence of hepatitis flare and hepatic decompensation after nucleos(t)ide analogue cessation in chronic hepatitis B patients

被引：0
|
作者：
Dongelmans, Edo J. [1 ]
Janssen, Harry L. A. [1 ,2 ]
机构：
[1] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Univ Hlth Network, Toronto Gen Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada
来源：
JOURNAL OF HEPATOLOGY | 2025年 / 82卷 / 04期
关键词：
D O I：
10.1016/j.jhep.2024.11.044
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：e174 / e175
页数：2
相关论文
共 50 条
  • [1] Hepatitis B Flare After Cessation of Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B: To Retreat or Not to Retreat
    Liaw, Yun-Fan
    HEPATOLOGY, 2021, 73 (02) : 843 - 852
  • [2] Letter: Safety after cessation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B infection
    Liu, Yen-Chun
    Jeng, Wen-Juei
    Chien, Rong-Nan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (07) : 731 - 732
  • [3] 48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patients
    Gao, Li
    Hu, Yue
    Shi, Xiaofeng
    Li, Xin
    Zhang, Dazhi
    Ren, Hong
    ANNALS OF HEPATOLOGY, 2020, 19 (03) : 329 - 334
  • [4] Adherence to nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B
    Manolakopoulos, Spilios
    Goulis, John
    Striki, Athanasia
    Deutsch, Melanie
    Perlepe, Nikoleta
    Triantos, Christos
    Papatheodoridis, George V.
    GASTROENTEROLOGY, 2015, 148 (04) : S1068 - S1068
  • [5] Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B
    Jeng, Wen-Juei
    Chen, Yi-Cheng
    Chien, Rong-Nan
    Sheen, I-Shyan
    Liaw, Yun-Fan
    HEPATOLOGY, 2018, 68 (02) : 425 - 434
  • [6] Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
    Kim, Soon Sun
    Cheong, Jae Youn
    Cho, Sung Won
    GUT AND LIVER, 2011, 5 (03) : 278 - 287
  • [7] The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogue Cessation Among Asian Chronic Hepatitis B Patients: Friend or Foe?
    Wang, Chia-Chi
    Kao, Jia-Horng
    HEPATOLOGY, 2019, 69 (04) : 1843 - 1843
  • [8] CHRONIC HEPATITIS B PATIENTS REFERRED FOR LIVER TRANSPLANTATION AFTER NUCLEOS(T)IDE ANALOGUE DISCONTINUATION
    Hirode, Grishma
    Pi, Steven
    Kim, Audrey
    Feld, Jordan J.
    Bhat, Mamatha
    Van Uum, Rafique
    Lilly, Les
    Selzner, Nazia
    Hansen, Bettina E.
    Janssen, Harry L. A.
    HEPATOLOGY, 2021, 74 : 913A - 914A
  • [9] Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?
    Moreno-Cubero, Elia
    Sanchez del Arco, Robert T.
    Pena-Asensio, Julia
    Sanz de Villalobos, Eduardo
    Miquel, Joaquin
    Ramon Larrubia, Juan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (17) : 1825 - 1838
  • [10] New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence
    Cholongitas, Evangelos
    Goulis, Ioannis
    Antoniadis, Nikolaos
    Fouzas, Ioannis
    Imvrios, George
    Papanikolaou, Vasilios
    Akriviadis, Evangelos
    TRANSPLANT INTERNATIONAL, 2014, 27 (10) : 1022 - 1028
12345